AVP BioPharma Consult ApS: Financial statements 2022
CVR: 37770426
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,125,468 and a net result of DKK 148,392 compared with DKK 260,721 the year before. That is a decrease of 6.3% compared with the year before. Equity in the 2022 report amounted to DKK 294,089. The solvency ratio was 59%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,125,468
- Profit/Loss
- DKK 148,392
- Equity
- DKK 294,089
- Total Assets
- DKK 498,486
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.1M | 148K | 294K | 1 |
| 2021 | - | 1.2M | 261K | 346K | 1 |
| 2020 | - | 1.1M | 190K | 295K | 1 |
| 2019 | - | 1.5M | 320K | 375K | 1 |
| 2018 | - | 1M | 71K | 126K | 1 |
Official annual report
Keep an eye on AVP BioPharma Consult ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
AVP BioPharma Consult ApS has published its annual report for 2021. Gross profit came to DKK 1,201,153, and the net result was DKK 260,721.
About AVP BioPharma Consult ApS
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.
